Status In progress
Process STA
ID number 967

Provisional Schedule

Committee meeting: 1 22 May 2018
Committee meeting: 2 19 July 2018
Expected publication 17 October 2018

Project Team

Project lead Thomas Feist

Email enquiries


Key events during the development of the guidance:

Date Update
29 September 2017 As you will be aware, the Department of Health has asked NICE to conduct an appraisal of masitinib for treating amyotrophic lateral sclerosis. Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, the deadline for submissions is now expected to be early February 2018.
04 August 2017 Invitation to participate
27 January 2017 Draft scope documents
05 December 2016 Referral

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance